Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Texas Scottish Rite Hospital for Children
- Study ID
- NCT02040714
- Status
- Enrolling By Invitation
Conditions
- Legg Calve Perthes Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Osteotomy + Long Term Non-Weight Bearing — PROCEDURESurgical procedure that improves femoral head containment, plus a post-operative protocol that requires patient to maintain non-weight bearing for 6 months.
- Osteotomy + Short Term Non-Weight Bearing — PROCEDURESurgical procedure that improves femoral head containment, plus a post-operative protocol that allows early return to function after 6 weeks of non-weight bearing.
- Nonoperative Observation — PROCEDUREGroup will not undergo any surgical or invasive procedures during course of treatment.
- Multiple Epiphyseal Drilling — PROCEDUREMultiple epiphyseal drilling is a procedure that creates small holes in the femoral head growth plate to increase blood flow into the femoral head.
Study Details
Legg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a significant public health problem (affects 1 in 740 boys between ages 0-14), but uncommon enough to have a sufficient number of patients from a single institution to perform a definitive prospective study comparing the results of current treatments. The present study will establish a database of prospectively identified patients with Legg-Calvé-Perthes (LCP) Disease and collect information regarding their presentation, treatment, and outcomes in the course of receiving currently available treatments. This study seeks to compare the outcomes of current treatments in the management of different age groups (ages 1-6, 6-8, 8-11, \>11) of patients with Perthes disease at two- and five-year followup and at skeletal maturity. For each age group, two to three common treatment regimens currently used by practicing pediatric orthopaedic surgeons will be compared. The intervention a patient receives is determined through physician treatment expertise, and is not pre-determined by the study.
Key Dates
- Start date
- Aug 31, 2012
- Status verified
- May 2025
- Primary completion
- Sep 30, 2032
- Completion
- Sep 30, 2032
Study Design
- Enrollment
- 1,500 participants (estimated)
Arms
- Arm: Nonoperative management between ages 6-8 in early stageThe choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
- Arm: Operative management between age 6-8 in early stageOperative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) rendered in the early stage of the disease process
- Arm: Nonoperative management between age 8-11 in early stagePatients who do not undergo some form of containment surgery because of medical, social, or other reasons will receive no surgical treatment.
- Arm: Operative containment with short-term non-weightbearing in early stageAs per the current standard practice for patients between age 8-11 in developed countries, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 weeks of non-weight bearing on the operated leg.
- Arm: Operative containment with prolonged non-weightbearing in early stageAs per the current standard practice for patients between age 8-11, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better "contain" the femoral head underneath the acetabulum. Post-operative treatment will include 6 months of non-weight bearing on the operated leg.
- Arm: Operative containment for over 11 age groupPatients presenting over age 11 may receive multiple drilling and be non weight bearing for up to 6 months according to the treating physician's preference. Patients with application of fixator (arthrodiastasis) will be studied in this cohort arm as well, which typically involved 3-4 months followed by 8-12 weeks of non-weight bearing after fixator removal. Other surgical techniques may be included, however these are the most common for this age group.
- Arm: Nonoperative management in over 11 age groupPatients will be non-weight bearing and receive physical therapy according to the physician preferences.
- Arm: Nonoperative management in 1-6 age groupThe choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
- Arm: Operative management in 1-6 age groupThe choice of osteotomy management with containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
- Arm: Late Stage Bracing groupPatients presenting with \<= 20 degrees of abduction on a maximum abduction x-ray treated with bracing who also present in the late stages of the disease (Waldenstrom Stage IIb or IIIa).The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
- Arm: Late Stage Symptomatic treatment groupPatients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated symptomatically. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
- Arm: Late Stage Surgical Containment groupPatients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated with surgical containment. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).
Primary Outcome Measure
Sphericity deviation score of the femoral head [ Time Frame: 5 years post intervention ]